These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6635970)

  • 1. [Hemodialysis and metabolism of erythrocyte porphyrins in patients with chronic glomerulonephritis].
    Chernova EI; Riabov SI; Chizhikova VA
    Ter Arkh; 1983; 55(9):131-4. PubMed ID: 6635970
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mononuclear cell magnesium content in patients with chronic glomerulonephritis and on regular hemodialysis treatment].
    Mori T
    Nihon Jinzo Gakkai Shi; 1985 Aug; 27(8):1185-91. PubMed ID: 4087538
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodialysis effect on the biosynthesis of porphyrins.
    Pisanetz M; Velichkova E; Ovanesian M
    Folia Med (Plovdiv); 1981; 23(3-4):56-60. PubMed ID: 6804338
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphology of diffuse glomerulonephritis during chronic intermittent hemodialysis].
    Jenó O; Anikó M; Zsuzsanna K; György G
    Orv Hetil; 1974 Dec; 115(50):2972-5. PubMed ID: 4453413
    [No Abstract]   [Full Text] [Related]  

  • 5. [The blood pro- and antioxidant status in patients with chronic glomerulonephritis and disordered kidney function undergoing treatment with peroral sorbents].
    Tugusheva FA; Kulikova AI; Lukichev BG; Zubina IM
    Urol Nefrol (Mosk); 1994; (6):39-42. PubMed ID: 7892720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI; Gorbunova NA
    Ter Arkh; 1997; 69(7):46-50. PubMed ID: 9424758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum and urine lysozyme in chronic pyelonephritis and chronic glomerulonephritis].
    Klein U; Klein YM; Stein G; Stelzner A
    Z Urol Nephrol; 1981 May; 74(5):375-84. PubMed ID: 7269823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma porphyrins in patients treated with hemodialysis].
    Cancarini GC; Ravelli M; Mombelloni S; Topi GC; D'Alessandro Gandolfo L; De Costanza F; Maiorca R
    Minerva Nefrol; 1981; 28(3):311-4. PubMed ID: 7329608
    [No Abstract]   [Full Text] [Related]  

  • 9. Potassium flux of erythrocytes in chronic hemodialysis patients.
    Ozawa Y; Imafuku Y; Nishi S; Yoshida H
    Clin Chim Acta; 2004 Dec; 350(1-2):189-93. PubMed ID: 15530477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrogenic anemia and porphyrin biosynthesis].
    Ivanov E; Pisanets M
    Vutr Boles; 1983; 22(4):18-24. PubMed ID: 6675278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity and prognosis in patients with chronic glomerulonephritis treated without hemodialysis.
    Kaneko Y
    Jpn Circ J; 1975 Jul; 39(7):811-3. PubMed ID: 1159941
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Sardh E; Andersson DE; Henrichson A; Harper P
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):66-71. PubMed ID: 19268004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
    Gafter U; Mamet R; Korzets A; Malachi T; Schoenfeld N
    Nephrol Dial Transplant; 1996 Sep; 11(9):1787-91. PubMed ID: 8918623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
    Ohi H; Tamano M; Sudo S; Okada N
    Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients on hemodialysis therapy for more than 30 years.
    Otsubo S; Otsubo K; Sugimoto H; Ueda S; Otsubo Y; Otsubo O; Yajima A; Yagi S; Kataoka H; Iwasaki T; Iwasa Y; Takahashi M; Aoki A; Ino J; Uchida K; Yumura W; Akiba T; Nitta K
    Ther Apher Dial; 2007 Aug; 11(4):274-9. PubMed ID: 17661833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte protoporphyrin in experimental chronic lead poisoning in calves.
    George JW; Duncan JR
    Am J Vet Res; 1981 Sep; 42(9):1630-7. PubMed ID: 7325474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
    Rud'ko IA; Kubatiev AA; Tsalenchuk IaP
    Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced aminolevulinic dehydrase activity with increased blood porphyrins in experimental chronic renal failure.
    Fontanellas A; Torralbo A; Santos JL; Morán MJ; Barrientos A; Enríquez de Salamanca R
    Exp Nephrol; 1997; 5(1):95-9. PubMed ID: 9052854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Entity of erythrocyte incorporation of potassium (Rb 86) studies by the in vitro incubation technic in uremic subject under continuous hemodialysis].
    Sitia L; Bandiani G
    Arch Maragliano Patol Clin; 1969; 25(3):181-4. PubMed ID: 5409171
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
    de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
    Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.